Citation Impact
Citing Papers
De novo design of transmembrane β barrels
2021 StandoutScienceNobel
De novo design of allosterically switchable protein assemblies
2024 StandoutNatureNobel
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR
2015 Standout
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
Differential analysis of gene regulation at transcript resolution with RNA-seq
2012 Standout
Cystic fibrosis
2016 Standout
Hemoglobin: Structure, Function and Allostery
2020
Nonenzymatic Deamidation of Asparaginyl and Glutaminyl Residues in Protein
1991
The molecular basis of blood coagulation
1988 Standout
Ivacaftor potentiation of multiple CFTR channels with gating mutations
2012
Understanding, improving and using green fluorescent proteins
1995 StandoutNobel
Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: targeting via ubiquitination of the N-terminal residue
2000 StandoutNobel
A cell stress signaling model of fetal hemoglobin induction: what doesn't kill red blood cells may make them stronger
2008
Plant Polyphenols: Chemical Properties, Biological Activities, and Synthesis
2011 Standout
Alternative Splicing of RNA Triplets Is Often Regulated and Accelerates Proteome Evolution
2012
Cystic fibrosis genetics: from molecular understanding to clinical application
2014 Standout
CFTR: folding, misfolding and correcting the ΔF508 conformational defect
2011
Overcoming Hysteresis to Attain Reversible Equilibrium Folding for Outer Membrane Phospholipase A in Phospholipid Bilayers
2011
Sickle-cell disease
2010 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
mRNA transcript therapy
2014 StandoutNobel
Hyperthermophilic Enzymes: Sources, Uses, and Molecular Mechanisms for Thermostability
2001 Standout
Homology requirements for unequal crossing over in humans.
1991 StandoutNobel
Chloride channels as drug targets
2008
Update on Key Emerging Challenges in Cystic Fibrosis
2014 Standout
Complementary DNA sequences of two 14.5 kDa subunits of NADH:ubiquinone oxidoreductase from bovine heart mitochondria Completion of the primary structure of the complex?
1992 StandoutNobel
Effect of resveratrol on cell cycle proteins in murine transplantable liver cancer
2003
Position-independent, high-level expression of the human β-globin gene in transgenic mice
1987 Standout
Molecular cloning and sequence analysis of an Azospirilium brasilense indole-3-pyruvate decarboxylase gene
1994
Degradation of Myogenic Transcription Factor MyoD by the Ubiquitin Pathway In Vivo and In Vitro: Regulation by Specific DNA Binding
1998 StandoutNobel
Spectroscopic studies of protein-heme interactions accompanying the allosteric transition in methemoglobins
1985 StandoutNobel
Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
2004 Standout
THE GREEN FLUORESCENT PROTEIN
1998 StandoutNobel
Probing the energetics of proteins through structural perturbation: sites of regulatory energy in human hemoglobin.
1982
MOLECULAR GENETICS OF HUMAN HEMOGLOBIN
1976
Resveratrol blocks interleukin-1β–induced activation of the nuclear transcription factor NF-κB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells
2003
Abnormal processing of beta Knossos RNA
1984
Protein synthesis elongation factor EF-1 alpha is essential for ubiquitin-dependent degradation of certain N alpha-acetylated proteins and may be substituted for by the bacterial elongation factor EF-Tu.
1994 StandoutNobel
Molecular basis of hemophilia B: a defective enzyme due to an unprocessed propeptide is caused by a point mutation in the factor IX precursor.
1986
Identification of the Cystic Fibrosis Gene: Genetic Analysis
1989 StandoutScience
In Vivo Half-Life of a Protein Is a Function of Its Amino-Terminal Residue
1986 StandoutScience
REACTIVE OXYGEN SPECIES: Metabolism, Oxidative Stress, and Signal Transduction
2004 Standout
Structural and Functional Analysis of an mRNP Complex That Mediates the High Stability of Human β-Globin mRNA
2001
The Association of Hemoglobin Knossos and Hemoglobin Lepore in an Algerian Patient
1984
Amino-terminal processing of proteins: hemoglobin South Florida, a variant with retention of initiator methionine and N alpha-acetylation.
1985
Molecular targets of dietary agents for prevention and therapy of cancer
2006 Standout
Oxidative Stress Increased Respiration and Generation of Reactive Oxygen Species, Resulting in ATP Depletion, Opening of Mitochondrial Permeability Transition, and Programmed Cell Death
2002
Degradation of the tumor suppressor protein p53 by the ubiquitin-mediated proteolytic system requires a novel species of ubiquitin-carrier protein, E2
1994 StandoutNobel
Plant growth promoting rhizobacteria as biofertilizers
2003 Standout
Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway
1998 StandoutNobel
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
The silent carrier allele: β thalassemia without a mutation in the β-globin gene or its immediate flanking regions
1984 StandoutNobel
Affinity purification of ubiquitin-protein ligase on immobilized protein substrates. Evidence for the existence of separate NH2-terminal binding sites on a single enzyme.
1990 StandoutNobel
Ubiquitin-mediated protein degradation.
1988 StandoutNobel
Silent β-Thalassemia Associated with Hb Knossos β27 (B9) Ala→Ser in Algeria
1983
Cotranslational amino-terminal processing of cytosolic proteins. Cell-free expression of site-directed mutants of human hemoglobin.
1988
Hemoglobin S Antilles: a variant with lower solubility than hemoglobin S and producing sickle cell disease in heterozygotes.
1986
Quantification of the close association between DNA haplotypes and specific β-thalassaemia mutations in Mediterraneans
1984 Nature
Works of N. Arous being referenced
Mutation-Specific Potency and Efficacy of Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Potentiators
2009
Alternative Splicing at a NAGNAG Acceptor Site as a Novel Phenotype Modifier
2010
Resveratrol, a natural dietary phytoalexin, possesses similar properties to hydroxyurea towards erythroid differentiation
2001
COMMD1-Mediated Ubiquitination Regulates CFTR Trafficking
2011
Two Mild Cystic Fibrosis-associated Mutations Result in Severe Cystic Fibrosis When Combined in Cis and Reveal a Residue Important for Cystic Fibrosis Transmembrane Conductance Regulator Processing and Function
2001
Hemoglobin Saverne: A New Variant with Elongated β Chains: Structural and Functional Properties
1988
Structural and functional studies of hemoglobin Poissy a2β256 (D7) Gly → Arg and 86 (F2) Ala → Pro
1985
Hemoglobin Hotel-Dieu β599 ASP → GLY (Gl). A New Abnormal Hemoglobin with high Oxygen Affinity
1981
Evidence for direct CFTR inhibition by CFTRinh-172 based on Arg347 mutagenesis
2008
Hemoglobin Saint Mandé β102 (G4) Asn → Tyr: a new low oxygen affinity variant
1981
Structural study of hemoglobin Knossos, β27 (B9) Ala→Ser
1982
A new Case of Hemoglobin Providence (α2β282 (Ef6) Lys → Asn or Asp) Discovered in a French Caucasian Family. Structural and Functional Studies
1985
Hb Strasbourg α2β220 (B2) Val → Asp: A variant at the same locus as Hb olympia β20 Val → Met
1976
Hemoglobin C Ziguinchor αA2β62 (A3)Glu → Val β58(E2)→ Arg: The second sickling variant with amino acid substitutions in 2 residues of the β polypeptide chain
1975
Hb Henri Mondor: β26 (B8) Glu → Val: A variant with a substitution localized at the same position as that of HbE β26 Glu → Lys
1976
Hb Marseille [α2β2 N methionyl ‐ 2 (NA2) His → Pro]: a new β chain variant having an extended N‐terminus
1984